Compare · CCEL vs PARK
CCEL vs PARK
Side-by-side comparison of Cryo-Cell International Inc. (CCEL) and Park Dental Partners Inc. (PARK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CCEL and PARK operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- PARK is the larger of the two at $118.9M, about 3.0x CCEL ($39.1M).
- PARK has been more active in the news (8 items in the past 4 weeks vs 3 for CCEL).
- PARK has more recent analyst coverage (2 ratings vs 0 for CCEL).
- Company
- Cryo-Cell International Inc.
- Park Dental Partners Inc.
- Price
- -
- -
- Market cap
- $39.1M
- $118.9M
- 1M return
- -
- +14.29%
- 1Y return
- -
- +100.33%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- AMEX
- NASDAQ
- IPO
- 2022
- 2025
- News (4w)
- 3
- 8
- Recent ratings
- 0
- 2
Cryo-Cell International Inc.
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Latest CCEL
- SEC Form 8-K filed by Cryo-Cell International Inc.
- SEC Form 4 filed by Cryo-Cell International Inc.
- SEC Form 4 filed by Cryo-Cell International Inc.
- SEC Form DEF 14A filed by Cryo-Cell International Inc.
- SEC Form 10-Q filed by Cryo-Cell International Inc.
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results
- SEC Form 8-K filed by Cryo-Cell International Inc.
- Chairman, Co-CEO Portnoy David acquired $799,995 worth of shares (600,191 units at $1.33) and disposed of $799,995 worth of shares (600,191 units at $1.33), decreasing direct ownership by 71% to 247,438 units (SEC Form 4)
- SEC Form 10-Q filed by Cryo-Cell International Inc.
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results
Latest PARK
- Amendment: Park Dental Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- CORRECTION -- Park Dental Partners Announces Third Quarter 2026 Results
- SEC Form 10-Q filed by Park Dental Partners Inc.
- Park Dental Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Park Dental Partners Announces Third Quarter 2026 Results
- Park Dental Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
- Park Dental Partners Completes Acquisition of Village Family Dental Support Services Organization, Expands into North Carolina
- Park Dental Partners Announces Dates for Third Quarter 2026 Earnings Release and Conference Call
- Amendment: SEC Form SCHEDULE 13G/A filed by Park Dental Partners Inc.
- SEC Form 8-K filed by Park Dental Partners Inc.